Anti-TGFB1 Therapeutic Antibody (Metelimumab)
Recombinant human monoclonal antibody expressed in CHO binding to human TGFB1. Metelimumab is a human IgG4 monoclonal antibody that neutralizes TGF beta 1 which had been chosen for further development for the treatment of diffuse cutaneous systemic sclerosis, also known as scleroderma.
| Supplier | Creative Biolabs |
|---|---|
| Product # | TAB-762 |
| Pricing | Inquiry |
| Host | Human |
| Target | TGFB1 |
| Species Reactivity | Human |
| Type | IgG4 - kappa |
| Applications | Suitable for use in IF, IP, Neut, FuncS, ELISA, FC, ICC and most other immunological methods. |
| Storage | Store it under sterile conditions at -20°C upon receiving. Recommend to pack the protein into smaller quantities for optimal storage. |